Whether you are an international company focusing on the region or a Swiss company looking to expand globally, our team of lawyers can help.

We have established a reputation for advising clients on a variety of matters involving Switzerland over a number of years.

This has involved developing close relationships with leading Swiss counsel and working collaboratively with them. We combine our transactional, contentious, and regulatory experience with an appreciation of local practice and expectations to ensure our clients' goals are met.

Our Switzerland group comprises lawyers from across our international networks and from across a wide range of capabilities, enabling us to advise clients on the full spectrum of legal matters. These include, for example, large M&A matters, cross-border disputes and arbitrations, capital markets transactions, financings and transactions in the energy & mining, pharma & healthcare, consumer, real estate and infrastructure sectors.

Download our Switzerland Group brochure

Experience

Coca-Cola HBC

Coca-Cola HBC, a Swiss-listed company listed on its acquisition of a 75% shareholding in Coca-Cola Beverages Africa Pty Ltd (“CCBA”) from The Coca-Cola Company and Gutsche Family Investments Pty Ltd for a combined purchase price of US$2.6 billion, implying an equity value for 100% of CCBA at US$3.4 billion

KKR

KKR in connection with the acquisition by Lonza Group AG (Swiss chemistry group) of the leading biopharmaceutical company Capsugel S.A. for an amount of USD 5.5 billion (including the refinancing of Capsugel's existing debt of around USD 2 billion)

Merrill Lynch Equities (Australia) Limited and Goldman Sachs Australia Pty Ltd

Merrill Lynch Equities (Australia) Limited and Goldman Sachs Australia Pty Ltd as the Joint Lead Managers of CSL’s A$6.3 billion placement to institutional investors, to partially fund the A$16.4 billion acquisition of Vifor Pharma, a Switzerland-based global specialty pharmaceutical company with leadership in iron deficiency, nephrology & cardio-renal therapies

Swiss Re

Swiss Re on its US$7.4 billion acquisition of GE Insurance Solutions, creating a new world market-leader in the field of reinsurance, using a transfer scheme

GS and UBS

GS and UBS as financial advisors of Zurich Insurance on its takeover of Beazley plc

Dr Reddy’s Laboratories Limited

Dr Reddy’s Laboratories Limited on the acquisition of Haleon Plc’s nicotine replacement therapy business for £500m held by a Swiss entity (said to be one of the biggest outbound from India in this space)

Stay in the know

Receive timely insights and briefings from HSF Kramer, tailored to keep you informed and ahead

Subscribe now
Hospitality and leisure Consumer